Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms
Authors:
- 23 October 2009
- journal article
- other
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 9 (11) , 842-843
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- CYP2D6 and tamoxifen: DNA matters in breast cancerNature Reviews Cancer, 2009
- Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolismAnnals of Oncology, 2007
- Pharmacogenetic Screening of the Gene Deletion and Duplications of CYP2D6Drug Metabolism Reviews, 2007
- The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenBreast Cancer Research and Treatment, 2006
- The 2988G>A polymorphism affects splicing of a CYP2D6 minigeneClinical Pharmacology & Therapeutics, 2006
- Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing eventsPharmacogenetics and Genomics, 2006
- Copy number variation: New insights in genome diversityGenome Research, 2006
- Determination of Cytochrome P450 2D6 (CYP2D6) Gene Copy Number by Real‐Time Quantitative PCRBioMed Research International, 2005
- CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-rime PCRHuman Mutation, 2003
- CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendantsPharmacogenomics, 2002